This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Lamotrigine and Rash: Scratching Beneath the Surface

David M. Labiner

Published: November 1, 2002

Article Abstract

That lamotrigine is an effective medication in the treatment of epilepsy and psychiatric disease is not debatable. Numerous well-designed clinical trials have demonstrated efficacy and safety in both neurologic and psychiatric disorders. Why, then, do many practitioners in neurology as well as psychiatry steer away from using this medication? Clearly, it seems that the "rash issue" taints the perception of safety.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 63

Quick Links: Epilepsy , Neurodevelopmental

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...